Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: A Randomized Phase III Trial of Oxaliplatin (OXAL) plus 5-Fluorouracil (5-FU)/Leucovorin (CF) with or without Cetuximab (C225) after Curative Resection for Patients with Stage III Colon CancerCIRB: Adult CIRB - Late Phase EmphasisLead Group: NCCTGStatus: Closed to Accrual. Pts Have Completed InterventionReview Status: Available to Open
